Publications
Publications 14751 - 14775 de 33557
| Titre | DOI |
|---|---|
|
HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population A. Nahet; L. Boublenza; H. Hassaine; N. Masdoua; J.L. Pretet; E. Belglaiaa; C. Mougin 2016 |
10.1016/j.bulcan.2016.02.016 |
|
HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources A. Lebeau; D. Bruyere; P. Roncarati; P. Peixoto; E. Hervouet; G. Cobraiville; B. Taminiau; M. Masson; C. Gallego; G. Mazzucchelli; N. Smargiasso; M. Fleron; D. Baiwir; E. Hendrick; C. Pilard; T. Lerho; C. Reynders; M. Ancion; R. Greimers; J.C. Twizere; G. Daube; G. Schlecht-Louf; F. Bachelerie; J.D. Combes; P. Melin; M. Fillet; P. Delvenne; P. Hubert; M. Herfs 2022 |
10.1038/s41467-022-28724-8 |
|
HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar D. Culie; A. Rousseau; J.L. Pretet; J.Lacau Sain Guily Submitted |
10.1007/s00405-021-07117-5 |
|
HPV testing in the screening and follow-up of patients with cervical high-grade squamous intraepithelial lesions C. Gonthier; C. Desportes; J.L. Pretet; H. Azais; C. Uzan; J.L. Mergui; G. Canlorbe 2019 |
10.1016/j.gofs.2019.09.004 |
|
HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study A. Baumann; J. Henriques; Z. Selmani; A. Meurisse; Q. Lepiller; D. Vernerey; S. Valmary-Degano; S. Paget-Bailly; D. Riethmuller; R. Ramanah; C. Mougin; J.L. Pretet 2021 |
10.3390/cancers13164149 |
|
HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report R. Boidot; S. Chevrier; V. Julie; S. Ladoire; F. Ghiringhelli 2016 |
10.1007/s00384-015-2448-7 |
|
HS-AFM and SERS Analysis of Murine Norovirus Infection: Involvement of the Lipid Rafts E.N. Aybeke; G. Belliot; S. Lemaire-Ewing; M. Estienney; Y. Lacroute; P. Pothier; E. Bourillot; E. Lesniewska 2017 |
10.1002/smll.201600918 |
|
HSP110 promotes colorectal cancer growth through STAT3 activation K. Berthenet; A.'dem Bokhari; A. Lagrange; G. Marcion; C. Boudesco; S. Causse; A. De Thonel; M. Svrcek; A.R. Goloudina; S. Dumont; A. Hammann; D.S. Biard; O.N. Demidov; R. Seigneuric; A. Duval; A. Collura; G. Jego; C. Garrido 2017 |
10.1038/onc.2016.403 |
|
HSP110 sustains chronic NF-kappa B signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization C. Boudesco; E. Verhoeyen; L. Martin; C. Chassagne-Clement; L. Salmi; R. Mhaidly; C. Pangault; T. Fest; S. Ramla; F. Jardin; O.O. Wolz; A.N.R. Weber; C. Garrido; G. Jego 2018 |
10.1182/blood-2017-12-819706 |
|
HSP110 SUSTAINS MYD88-DEPENDENT NFKB SIGNALING IN ACTIVATED B CELL DIFFUSE LARGE B CELL LYMPHOMA C. Boudesco; S. Causse; A. Hamman; E. Verhoeyen; L. Martin; F. Jardin; T. Fest; O. Wolz; A. Weber; C. Garrido; G. Jego 2017 |
|
|
HSP110 SUSTAINS MYD88-DEPENDENT NFKB SIGNALING IN ACTIVATED B CELL DIFFUSE LARGE B CELL LYMPHOMA C. Boudesco; S. Causse; A. Hamman; E. Verhoeyen; L. Martin; F. Jardin; T. Fest; O. Wolz; A. Weber; C. Garrido; G. Jego 2017 |
|
|
HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer O. Buhard; A. Lagrange; A. Guilloux; C. Colas; M. Chouchene; K. Wanherdrick; F. Coulet; E. Guillerm; C. Dorard; L. Marisa; A. Bokhari; M. Greene; N. El-Murr; S. Bodo; M. Muleris; I. Sourouille; M. Svrcek; P. Cervera; H. Blanche; J.H. Lefevre; Y. Parc; C. Lepage; C. Chapusot; A.M. Bouvier; M.P. Gaub; J. Selves; K. Garrett; B. Iacopetta; R. Soong; R. Hamelin; C. Garrido; O. Lascols; T. Andre; J.F. Flejou; A. Collura; A. Duval 2016 |
10.1136/jmedgenet-2015-103518 |
|
HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells S.Z. Causse; G. Marcion; G. Chanteloup; B. Uyanik; C. Boudesco; B.B. Grigorash; R. Douhard; A.M.M. Dias; B. Dumetier; L. Dondaine; G.J. Gozzi; E. Moussay; J. Paggetti; C. Mirjolet; A. de Thonel; L. Dubrez; O.N. Demidov; J. Gobbo; C. Garrido 2019 |
10.1038/s41388-018-0616-2 |
|
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis M. Sevin; L. Kubovcakova; N. Pernet; S. Causse; F. Vitte; J.Luc Villeval; C. Lacout; M. Cordonnier; F. Rodrigues-Lima; G. Chanteloup; M. Mosca; M.L. Chretien; J.Noel Bastie; S. Audia; P. Sagot; S. Ramla; L. Martin; M. Gleave; V. Mezger; R. Skoda; I. Plo; C. Garrido; F. Girodon; A. de Thonel 2018 |
10.1038/s41467-018-03627-9 |
|
HSP27: A new target for treating idiopathic pulmonary fibrosis? L. Pommerolle; O. Burgy; P. Bonniaud; F. Goirand 2020 |
10.1016/j.rmr.2020.02.007 |
|
HSP27: A Therapeutic Target in Myelofibrosis M. Sevin; N. Pernet; F. Vitte; S. Ramla; P. Sagot; L. Martin; J.Luc Villeval; C. Lacout; I. Plo; C. Garrido; F. Girodon; A. de Thonel 2016 |
10.1182/blood.V128.22.1963.1963 |
|
HSP47: a potential target for fibrotic diseases and implications for therapy P.S. Bellaye; O. Burgy; P. Bonniaud; M. Kolb 2021 |
10.1080/14728222.2021.1861249, Early Access Date = {JAN 2021 |
|
HSP47: a potential target for fibrotic diseases and implications for therapy P.S. Bellaye; O. Burgy; P. Bonniaud; M. Kolb 2021 |
10.1080/14728222.2021.1861249 |
|
HSP70 is a negative regulator of NLRP3 inflammasome activation P. Martine; A. Chevriaux; V. Derangere; L. Apetoh; C. Garrido; F. Ghiringhelli; C. Rebe 2019 |
10.1038/s41419-019-1491-7 |
|
HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia J.B. Arlet; J.A. Ribeil; F. Guillem; O. Negre; A. Hazoume; G. Marcion; Y. Beuzard; M. Dussiot; I.Cruz Moura; S. Demarest; I.Chauvot de Beauchene; Z. Belaid-Choucair; M. Sevin; T.Trovati Maciel; C. Auclair; P. Leboulch; S. Chretien; L. Tchertanov; V. Baudin-Creuza; R. Seigneuric; M. Fontenay; C. Garrido; O. Hermine; G. Courtois 2014 |
10.1038/nature13614 |
|
HSP70, the Key to Account for Erythroid Tropism of Diamond-Blackfan Anemia? M. Gastou; S. Rio; M. Dussiot; N. Karboul; T. Leblanc; M. Sevin; O. Bluteau; N. Mohandas; W. Vainchenker; C. Garrido; E. Solary; O. Hermine; L. Da Costa 2015 |
|
|
HSP70, the Key to Account for Erythroid Tropism of Diamond-Blackfan Anemia? M. Gastou; S. Rio; M. Dussiot; N. Karboul; T. Leblanc; M. Sevin; O. Bluteau; N. Mohandas; W. Vainchenker; C. Garrido; E. Solary; O. Hermine; L. Da Costa 2015 |
|
|
Hsp70: A Cancer Target Inside and Outside the Cell C. Boudesco; S. Cause; G. Jego; C. Garrido 2018 |
10.1007/978-1-4939-7477-1_27 |
|
HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms M. Sevin; F. Girodon; C. Garrido; A. de Thonel 2015 |
10.1155/2015/970242 |
|
HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias R. Mshaik; J. Simonet; A. Georgievski; L. Jamal; S. Bechoua; P. Ballerini; P.S. Bellaye; Z. Mlamla; J.P.Pais de Barros; A. Geissler; P.J. Francin; F. Girodon; C. Garrido; R. Quere 2021 |
10.1038/s41408-021-00450-2 |